SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-22-012361 to Orthofix Medical Inc. (OFIX) (CIK 0000884624) (OFIX)

Orthofix Medical Inc. (OFIX) (CIK 0000884624)
Date: Nov. 14, 2022 · CIK: 0000884624 · Accession: 0000000000-22-012361

Regulatory Compliance Financial Reporting Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-268234

Date
November 14, 2022
Author
Jon C. Serbousek
Form
UPLOAD
Company
Orthofix Medical Inc. (OFIX) (CIK 0000884624)

Letter

United States securities and exchange commission logo November 14, 2022 Jon C. Serbousek Chief Executive Officer Orthofix Medical Inc. 3451 Plano Parkway Lewisville, Texas 75056 Re:Orthofix Medical Inc. Registration Statement on Form S-4 Filed November 8, 2022 File No. 333-268234 Dear Jon C. Serbousek: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Abby Adams at (202) 551-6902 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Joseph E. Gilligan, Esq.

Show Raw Text
United States securities and exchange commission logo
November 14, 2022
Jon C. Serbousek
Chief Executive Officer
Orthofix Medical Inc.
3451 Plano Parkway
Lewisville, Texas 75056
Re:Orthofix Medical Inc.
Registration Statement on Form S-4
Filed November 8, 2022
File No. 333-268234
Dear Jon C. Serbousek:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Abby Adams at (202) 551-6902 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Joseph E. Gilligan, Esq.